is mounjaro a glp 1 medication Could GLP-1 Weight Loss Drugs Also Treat or Prevent Chronic Diseases? Mounjaro (Tirzepatide): Raising the Bar
Description
The analyses were conducted on the above cohorts: (1) SGLT2i and (2) GLP-1 RA with each analysis propensity score matched (PSM) for age, sex, BMI, presence of heart failure (ICD-10-CM-I50), hypertension (ICD-10-CM-I10), ischaemic heart disease (IHD) (ICD-10-CM-I2025), chronic kidney disease (CKD) (ICD-10-CM-N18) and HbA 1c value so as to balance the analysis (1:1 matching) being undertaken
report no conflicts of interest
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, for weight management in adults with obesity
Continued advancements in peptide therapeutics and expanding patient awareness contribute significantly to the market expansion over the forecast period
Ongoing clinical trials are expected to provide more insights into the safety, efficacy, and long-term benefits of using GLP-1 receptor agonists in mental health treatment
Gastric emptying often normalizes once a patient is on a stable dose
